Current Issue May 2012, Vol. 9, No. 5

Featured Article

Estradiol promotes sudden cardiac death in transgenic long QT type 2 rabbits while progesterone is protective  free full text

Free Press Articles

Deaths caused by the failure of Riata and Riata ST implantable cardioverter-defibrillator leads  free full text

In search of the shocking truth  free full text

Every Life Counts  free full text

Letter response to "Deaths Caused by the Failure of Riata and Riata ST Implantable Cardioverter-Defibrillator Leads," by Dr. Robert Hauser, et al.  free full text

Cause for Concern  free full text

2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design  free full text

PACES/HRS Expert Consensus Statement on the Management of the Asymptomatic Young Patient with a Wolff-Parkinson-White (WPW, Ventricular Preexcitation) Electrocardiographic Pattern: Developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology Foundation (ACCF), the American Heart Association (AHA), the American Academy of Pediatrics (AAP), and the Canadian Heart Rhythm Society (CHRS)

HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies

Genetic testing is increasingly important in determining potential cardiac conditions in patients and is used in clinical settings more than ever before. To ensure that physicians have up-to-date knowledge of the evolving role of genetic testing for sudden death predisposing, genetic heart diseases in cardiology, which can be life-saving for some patients, the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRS) have prepared HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies.
Read the full article

Embargo Policy

Abstracts are embargoed until the morning of the presentation. This means that information regarding any abstract submission may not be released before this time. Failure to honor embargo policies will result in the abstract being withdrawn and barred from presentation.

  • A stimulating environment for the atrial kick: Spinal cord stimulation can inhibit atrial fibrillation
    17 May 2012

    Yoram Etzion

  • Beat-to-beat variability of repolarization as a new biomarker for pro-arrhythmia in vivo
    17 May 2012

    Rosanne Varkevisser, Sofieke C. Wijers, Marcel A.G. van der Heyden, Jet D.M. Beekman, Mathias Meine, Marc A. Vos

  • Biological Pacemakers: the oscillatory road ahead
    14 May 2012

    Sandeep V. Pandit, José Jalife

  • High frequency stimulation of the atria increases early recurrence following pulmonary vein isolation in patients with persistent atrial fibrillation
    14 May 2012

    Akinori Sairaku, Yukihiko Yoshida, Hiroki Kamiya, Yasushi Tatematsu, Mamoru Nanasato, Haruo Hirayama, Yukiko Nakano, Yasuki Kihara

  • Cell-Specific Nanoplatform-Enabled Photodynamic Therapy for Cardiac Cells
    14 May 2012

    Uma Mahesh R. Avula, Gwangseong Kim, Yong-Eun Koo Lee, Fred Morady, Raoul Kopelman, Jérôme Kalifa

    • View More Articles in Press...




Current Issue

Cover Image

New Issue Alert

Free Trial Issue

Journal Ranking

About the Journal

HeartRhythm, the official journal of the Heart Rhythm Society and the Cardiac Electrophysiology Society, provides rapid online and print publication of the most important basic and clinical scientific developments devoted to arrhythmias, devices and cardiovascular electrophysiology. The Journal is the only EP publication serving the entire electrophysiology community from basic to clinical academic researchers, private practitioners, allied health professionals, industry and trainees.

Publishing Information

Heart Rhythm is published by Elsevier for the Heart Rhythm Society



Access this journal onSciVerse ScienceDirect
Print or Share This Page

Call for Applications: HeartRhythm Journal Editor-in-Chief Search

After nearly a decade of dedicated service developing HeartRhythm Journal into the premier scientific publication serving the entire electrophysiology community, founding Editor-in-Chief Douglas P. Zipes, MD, FHRS, will end his term on December 31, 2013. Applications are now invited for the position of Editor-in-Chief of HeartRhythm. Interested applicants should submit a curriculum vitae, the names of three references, and a letter of intent describing vision for the journal and unique qualifications for this position.
Learn more

Pirfenidone mitigates left ventricular fibrosis and dysfunction after myocardial infarction and reduces arrhythmias

Video--flashvideo1hrthm--http://podcasts.elsevierhealth.com/hrthm/hrthm_PIIS1547527110004054_mmc3.flv--/webfiles/images/journals/hrthm/video.gifhealthadvance--1547-5271--15.00--hp_10012010_V1--www.heartrhythmjournal.com

About HRS

Heart Rhythm Society is the only national membership organization dedicated to informing health professionals and their patients about heart rhythm disorders, cardiac arrhythmias, cardiac death, and their treatments. Through research, education, and clinical practice, Heart Rhythm Society provides life-enhancing heart rhythm management and advances the highest standards of patient care.